Healthcare -
Biotechnology - NASDAQ - US
$ 9.61
-17.1 %
$ 482 M
Market Cap
-3.28
P/E
RGNX - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities RGNX - REGENXBIO Inc.
92.7 M
LAST VALUE
128.34%
2 YEAR CAGR
61.73%
5 YEAR CAGR
44.10%
10 YEAR CAGR